Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04676334
Title CATCH-R: A Rollover Study to Provide Continued Access to Rucaparib (CATCH-R)
Recruitment Enrolling by invitation
Gender both
Phase Phase III
Variant Requirements No
Sponsors Clovis Oncology, Inc.
Indications

peritoneum cancer

prostate cancer

fallopian tube cancer

Advanced Solid Tumor

ovarian cancer

ovary epithelial cancer

Therapies

Rucaparib

Age Groups: adult | senior
Covered Countries USA | ITA | ESP | CAN


No variant requirements are available.